Fredun [FREDUN] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Fredun

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fredun wins in 11 metrics, Suven Life Sciences wins in 7 metrics, with 0 ties. Fredun appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFredunSuven Life SciencesBetter
P/E Ratio (TTM)27.58-28.01Suven Life Sciences
Price-to-Book Ratio4.1340.49Fredun
Debt-to-Equity Ratio118.220.00Suven Life Sciences
PEG Ratio0.44-0.34Suven Life Sciences
EV/EBITDA12.85-23.32Suven Life Sciences
Profit Margin (TTM)4.50%84.44%Suven Life Sciences
Operating Margin (TTM)12.99%-2,791.92%Fredun
EBITDA Margin (TTM)12.99%N/AN/A
Return on Equity13.96%-146.15%Fredun
Return on Assets (TTM)4.05%-118.91%Fredun
Free Cash Flow (TTM)$-351.69M$-1.91BFredun
Dividend Yield0.09%N/AN/A
1-Year Return74.09%46.77%Fredun
Price-to-Sales Ratio (TTM)1.26641.26Fredun
Enterprise Value$7.89B$43.40BSuven Life Sciences
EV/Revenue Ratio1.59577.38Fredun
Gross Profit Margin (TTM)26.88%100.00%Suven Life Sciences
Revenue per Share (TTM)$1,128$0Fredun
Earnings per Share (Diluted)$48.08$-8.15Fredun
Beta (Stock Volatility)0.860.86Fredun
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fredun vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Fredun
Suven Life Sciences
Fredun Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fredun4.88%6.70%11.52%71.28%96.73%89.92%
Suven Life Sciences0.80%-0.17%-3.10%-15.83%58.82%63.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fredun74.09%27.27%443.09%11,052.80%11,052.80%11,052.80%
Suven Life Sciences46.77%186.97%307.88%-25.87%594.28%3,728.07%

News Based Sentiment: Fredun vs Suven Life Sciences

Fredun

News based Sentiment: POSITIVE

Fredun Pharmaceuticals experienced a remarkably positive month, achieving a new 52-week high, strong financial growth, and a commitment to shareholder returns. While the planned equity issuance introduces some complexity, the overall narrative is one of significant growth and market outperformance, making it a noteworthy event for investors.

View Fredun News Sentiment Analysis

Suven Life Sciences

News based Sentiment: POSITIVE

The month of October 2025 saw Suven Life Sciences benefit from both company-specific gains and a broader pharmaceutical rally, indicating a positive trend for the company. The Pfizer agreement acted as a catalyst for this positive movement, suggesting a favorable market environment.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Fredun vs Suven Life Sciences

MetricFREDUNSUVEN
Market Information
Market Cap i₹6.58B₹48.20B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i11,971185,019
90 Day Avg. Volume i16,431147,095
Last Close₹1,394.10₹208.70
52 Week Range₹635.00 - ₹1,395.65₹102.50 - ₹299.99
% from 52W High-0.11%-30.43%
All-Time High₹1,428.00 (Dec 05, 2022)₹338.50 (Apr 13, 2015)
% from All-Time High-2.37%-38.35%
Growth Metrics
Quarterly Revenue Growth0.52%0.86%
Quarterly Earnings Growth0.64%0.86%
Financial Health
Profit Margin (TTM) i0.05%0.84%
Operating Margin (TTM) i0.13%-27.92%
Return on Equity (TTM) i0.14%-1.46%
Debt to Equity (MRQ) i118.220.00
Cash & Liquidity
Book Value per Share (MRQ)₹321.10₹5.04
Cash per Share (MRQ)₹12.65₹2.75
Operating Cash Flow (TTM) i₹-1,140,997,000₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹197.39M₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield i0.09%N/A
Last 12-Month Dividend i₹0.70₹0.00

Valuation & Enterprise Metrics Analysis: Fredun vs Suven Life Sciences

MetricFREDUNSUVEN
Price Ratios
P/E Ratio (TTM) i27.58-28.01
Forward P/E iN/A10.55
PEG Ratio i0.44-0.34
Price to Sales (TTM) i1.26641.26
Price to Book (MRQ) i4.1340.49
Market Capitalization
Market Capitalization i₹6.58B₹48.20B
Enterprise Value i₹7.89B₹43.40B
Enterprise Value Metrics
Enterprise to Revenue i1.59577.38
Enterprise to EBITDA i12.85-23.32
Risk & Other Metrics
Beta i0.860.86
Book Value per Share (MRQ) i₹321.10₹5.04

Financial Statements Comparison: Fredun vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FREDUNSUVEN
Revenue/Sales i₹1.19B₹18.67M
Cost of Goods Sold i₹873.04M₹0
Gross Profit i₹320.99M₹18.67M
Research & Development i₹7.55M₹414.88M
Operating Income (EBIT) i₹155.72M₹-521.17M
EBITDA i₹169.91M₹-501.49M
Pre-Tax Income i₹90.40M₹-515.17M
Income Tax i₹22.75M₹0
Net Income (Profit) i₹67.66M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FREDUNSUVEN
Cash & Equivalents i₹6.37M₹150.26M
Total Current Assets i₹4.28B₹754.72M
Total Current Liabilities i₹3.28B₹234.86M
Long-Term Debt i₹96.13MN/A
Total Shareholders Equity i₹1.41B₹1.10B
Retained Earnings i₹628.39M₹-6.01B
Property, Plant & Equipment i₹95.24M₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FREDUNSUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFREDUNSUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i11,971185,019
Average Daily Volume (90 Day) i16,431147,095
Shares Outstanding i4.72M218.07M
Float Shares i2.72M67.61M
% Held by Insiders i0.59%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Fredun vs Suven Life Sciences

MetricFREDUNSUVEN
Last 12-Month Dividend i₹0.70₹0.00
Last 12-Month Dividend Yield i0.09%N/A
3-Year Avg Annual Dividend i₹0.70₹0.00
3-Year Avg Dividend Yield i0.08%N/A
3-Year Total Dividends i₹2.10₹0.00
Ex-Dividend DateSep 23, 2024N/A